Home › Leiomyosarcoma › California
Leiomyosarcoma clinical trials in California
9 studies for Leiomyosarcoma are looking for participants at sites in California.
Cities in California
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- City of Hope Comprehensive Cancer Center, Duarte
- UCI Health-Chao Family Comp CC and Ambulatory Care, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT04031677Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05711615STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- University of California, San Francisco, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06975293Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07628634AOH1996 for the Treatment of Refractory Solid Tumors
- City of Hope Medical Center, Duarte
- City of Hope at Long Beach Elm, Long Beach
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT05227326Metastatic Leiomyosarcoma Biomarker Protocol
- Sarcoma Oncology Research Center, Santa Monica
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2026 · NCT05653388A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Precision NextGen Oncology and Research Center, Beverly Hills
- Sarcoma Oncology Center, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT06789172Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
- Sarcoma Oncology Center, Santa Monica
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT03016819Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
- Sant P Chawla, Santa Monica
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 24, 2025 · NCT04535271From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.